These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6968502)

  • 21. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
    Ballow M; Pantschenko AG
    Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
    [No Abstract]   [Full Text] [Related]  

  • 23. Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
    Tanaka H; Kawakami T; Yang ZB; Komiyama K; Omura S
    J Antibiot (Tokyo); 1989 Nov; 42(11):1722-4. PubMed ID: 2584153
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of intracellular deoxynucleoside triphosphate levels in DNA repair in human lymphocytes.
    Cohen A
    Adv Exp Med Biol; 1986; 195 Pt B():201-5. PubMed ID: 3490119
    [No Abstract]   [Full Text] [Related]  

  • 25. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease.
    Ullman B; Gudas LJ; Cohen A; Martin DW
    Cell; 1978 Jun; 14(2):365-75. PubMed ID: 208780
    [No Abstract]   [Full Text] [Related]  

  • 26. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antibody response in the presence of partial adenosine deaminase inhibition.
    Hoffman EA; Kopp WC; Moat AG
    Proc Soc Exp Biol Med; 1990 May; 194(1):36-42. PubMed ID: 2139230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of methylation by adenosine in adenosine deaminase-inhibited, phytohemagglutinin-stimulated human lymphocytes.
    Johnston JM; Kredich NM
    J Immunol; 1979 Jul; 123(1):97-103. PubMed ID: 448160
    [No Abstract]   [Full Text] [Related]  

  • 31. [Action of deoxyadenosine on nucleic acid synthesis by tumor cells in the presence of a deaminase inhibitor].
    Vornovitskaia GI; Ioannesiants IA; Borzenko BG; Shapot VS
    Vopr Med Khim; 1975; 21(2):192-5. PubMed ID: 166514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in deoxyadenosine production during human lymphocyte mitogenesis.
    Iizasa T; Carson DA
    Exp Cell Res; 1984 Mar; 151(1):264-7. PubMed ID: 6607841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EHNA is a poor inhibitor of deoxyadenosine catabolism in cultured human lymphocytes.
    Goday A; Simmonds HA; Webster DR; Morris GS
    Rev Esp Fisiol; 1985 Mar; 41(1):49-54. PubMed ID: 3923578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.
    Lowe JK; Gowans B; Brox L
    Cancer Res; 1977 Sep; 37(9):3013-7. PubMed ID: 301772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration of nucleotides and deoxynucleotides in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes. Effects of adenosine and deoxyadenosine.
    Peters GJ; De Abreu RA; Oosterhof A; Veerkamp JH
    Biochim Biophys Acta; 1983 Aug; 759(1-2):7-15. PubMed ID: 6603870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of inhibition of purine nucleoside phosphorylase and adenosine deaminase in patients treated with azathioprine.
    Maddocks JL; Al-Safi SA
    Br J Clin Pharmacol; 1985 Jan; 19(1):108-11. PubMed ID: 3919749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
    Ballet JJ; Insel R; Merler E; Rosen FS
    J Exp Med; 1976 May; 143(5):1271-6. PubMed ID: 1262787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.
    Glazer RI
    Cancer Chemother Pharmacol; 1980; 4(4):227-35. PubMed ID: 7002342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.